Microvascular complications: Evaluation and monitoring relevance to clinical practice, clinical trials, and drug development

Adam Greenstein, Mitra Tavakoli, Moaz Mojaddidi, Ahmed Al-Sunni, Glenn Matfin, Rayaz Malik

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The long-term microvascular complications of diabetes pose a major health burden. Although, much of the focus has been on the macrovascular complications, it is clear that the microvascular complications have a significant impact on both morbidity and mortality amongst diabetic patients. Indeed retinopathy, nephropathy, and neuropathy compete as the leading causes of premature blindness, end-stage renal disease, and non-traumatic lower-limb amputation, respectively. Furthermore, complications develop and progress in unison and indeed share many common risk factors. Effective evaluation and monitoring of these complications in clinical practice is clearly important, however, it is also relevant to clinical intervention studies, and drug development programs addressing microvascular complications. Novel diagnostic and therapeutic strategies are continually evolving in this area and will be discussed in more detail in this review.

Original languageEnglish
Pages (from-to)166-171
Number of pages6
JournalBritish Journal of Diabetes and Vascular Disease
Volume7
Issue number4
DOIs
Publication statusPublished - Jul 2007
Externally publishedYes

    Fingerprint

Keywords

  • Diagnosis
  • Nephropathy
  • Neuropathy
  • Retinopathy
  • Treatment

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this